title: [Hepatitis C recurrence after living donor and cadaveric liver transplantation].
abstract: OBJECTIVE
  To determine the recurrence of hepatitis C in patients subjected to living donor liver transplantation compared to those subjected to cadaveric liver transplantation.
  
  
  METHODS
  Of a total of 333 liver transplantations, 279 (83.8%) were cadaveric liver transplantation and 54 (16.2%) living donor liver transplantation. Hepatic cirrhosis due to hepatitis C virus was the most common indication of both cadaveric liver transplantation (82 patients) and living donor liver transplantation (19 patients). The electronic study protocols of all patients with hepatic cirrhosis due to hepatitis C virus were reviewed. All data, including patients' age and sex, laboratory tests, hepatitis C virus recurrence and acute rejection were evaluated statistically.
  
  
  RESULTS
  A total of 55 cadaveric liver transplantation and 10 living donor liver transplantation performed in patients with liver cirrhosis due to hepatitis C virus was included in the study. Clinical and laboratory characteristics of the two groups before the transplantation were similar, except for the prothrombin time that was higher for the cadaveric liver transplantation than the living donor liver transplantation (P = 0.04). Hepatitis C virus recurrence was similar in the cadaveric liver transplantation (n = 37; 69.3%) and living donor liver transplantation (n = 7; 70%) groups (P = 0.8). The incidence of acute rejection was similar in cadaveric liver transplantation (n = 27; 49%) and living donor liver transplantation (n = 2; 20%) groups (P = 0.08). Hepatitis C virus recurrence in patients of the cadaveric liver transplantation group who received bolus doses of corticosteroids (9 of 11 patients) was similar to the remained patients (28 of 44 patients) (P = 0.25). Recurrence was also similar in patients of the living donor liver transplantation group who received bolus doses of corticosteroids (one of one patient) in relation to those who did not receive them (six of nine patients) (P = 0.7).
  
  
  CONCLUSIONS
  Hepatitis C recurrence is similar in patients who underwent living donor liver transplantation or cadaveric liver transplantation.
authors.affiliation: Serviço de Cirurgia do Aparelho Digestivo e Transplante Hepático do Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, PR. coelhojcu@yahoo.com.br
authors.forename: Júlio Cezar Uili
authors.initials: JC
authors.lastname: Coelho
authors.forename: Luciano
authors.initials: L
authors.lastname: Okawa
authors.forename: Mônica Beatriz
authors.initials: MB
authors.lastname: Parolin
authors.forename: Alexandre Coutinho Teixeira de
authors.initials: AC
authors.lastname: Freitas
authors.forename: Jorge E Fouto
authors.initials: JE
authors.lastname: Matias
authors.forename: Alysson Rogério
authors.initials: AR
authors.lastname: Matioski
mesh_terms: D001938:Brazil / Q000453:epidemiology; D002102:Cadaver; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D019698:Hepatitis C, Chronic / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery* / Q000821:virology; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D019520:Living Donors / Q000706:statistics & numerical data*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012008:Recurrence
chemical_list: D005938:Glucocorticoids; D008775:Methylprednisolone